AlloVir Inc (ALVR)
0.7946
+0.03
(+4.14%)
USD |
NASDAQ |
Apr 23, 16:00
0.7873
-0.01
(-0.92%)
After-Hours: 20:00
AlloVir Cash from Financing (TTM)
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2021 | 0.232M |
September 30, 2021 | -0.187M |
June 30, 2021 | 291.98M |
March 31, 2021 | 291.98M |
December 31, 2020 | 291.98M |
Date | Value |
---|---|
September 30, 2020 | 292.33M |
June 30, 2020 | 0.00 |
March 31, 2020 | 120.95M |
December 31, 2019 | 120.92M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-0.187M
Minimum
Sep 2021
292.33M
Maximum
Sep 2020
156.69M
Average
120.95M
Median
Mar 2020
Cash from Financing (TTM) Benchmarks
Arcutis Biotherapeutics Inc | 101.32M |
CEL-SCI Corp | 8.678M |
AIM ImmunoTech Inc | 0.485M |
IGC Pharma Inc | 2.856M |
NovaBay Pharmaceuticals Inc | 1.91M |